Latest News

12345678910
PCAR Q1 Deep Dive: Margins Compress as Industry Volatility Weighs on Results
Trucking company PACCAR (NASDAQ:PCAR) fell short of the market’s revenue expectations in Q1 CY2026, with sales falling 8.9% year on year to $6.78 billion. It...
Via StockStory · April 29, 2026
The Top 5 Analyst Questions From Helix Energy Solutions’s Q1 Earnings Call
Helix Energy Solutions’ first quarter saw a positive market response, driven by revenue exceeding Wall Street expectations and steady operational execution a...
Via StockStory · April 29, 2026
ITRI Q1 Deep Dive: Project Timing Boosts Results, Guidance Reflects Near-Term Headwinds
Resource management provider Itron (NASDAQ:ITRI) announced better-than-expected revenue in Q1 CY2026, but sales fell by 3.3% year on year to $587 million. On...
Via StockStory · April 29, 2026
OMCL Q1 Deep Dive: Platform Expansion and Cost Controls Drive Margin Turnaround
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 14.9% year on year to $30...
Via StockStory · April 29, 2026
Top 10 Best Data Analytics Course in Punetalkmarkets.com
Via Talk Markets · April 29, 2026
Understanding Research Chemicals and Responsible Scientific Usetalkmarkets.com
Via Talk Markets · April 29, 2026
SPGI Q1 Deep Dive: AI Adoption, Market Volatility, and Energy Headwinds Shape Results
Financial intelligence company S&P Global (NYSE:SPGI) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 10.4% year on year ...
Via StockStory · April 29, 2026
WEX’s Q1 Earnings Call: Our Top 5 Analyst Questions
WEX’s first quarter was met with a significant negative market reaction, as investors focused on margin compression and macroeconomic volatility despite the ...
Via StockStory · April 29, 2026
Oceaneering’s Q1 Earnings Call: Our Top 5 Analyst Questions
Oceaneering’s first quarter results reflected stability in its core offshore and defense businesses, with management attributing steady revenue growth to str...
Via StockStory · April 29, 2026
Lumber Market Size, Growth & Share Review 2026-2035talkmarkets.com
Via Talk Markets · April 29, 2026
Thermal Coal Market Size, Share & Growth Report 2026-2035talkmarkets.com
Via Talk Markets · April 29, 2026
DNA Microarray Market Share, Size & Growth Insights-2035talkmarkets.com
Via Talk Markets · April 29, 2026
Period Panties (Menstrual Underwear) Market Growth, Size & Share Analysistalkmarkets.com
Via Talk Markets · April 29, 2026
GM Q1 Deep Dive: Mixed Signals as Digital Revenue Grows, Cost Pressures Persist
Automotive manufacturer General Motors (NYSE:GM) beat Wall Street’s revenue expectations in Q1 CY2026, but sales were flat year on year at $43.62 billion. It...
Via StockStory · April 29, 2026
5 Revealing Analyst Questions From IBM’s Q1 Earnings Call
IBM’s first quarter results exceeded Wall Street’s expectations for both revenue and non-GAAP earnings, driven by robust demand for AI-enabled infrastructure...
Via StockStory · April 29, 2026
5 Revealing Analyst Questions From Old Second Bancorp’s Q1 Earnings Call
Old Second Bancorp’s first quarter was marked by robust revenue growth but increased credit costs, which weighed on profitability and drove a negative market...
Via StockStory · April 29, 2026
Skin Packaging Market Share, Size & Growth Trendstalkmarkets.com
Via Talk Markets · April 29, 2026
Deli Meat Market Size, Share & Growth Report-2035talkmarkets.com
Via Talk Markets · April 29, 2026
3D Modeling Market Size, Share & Growth-2035talkmarkets.com
Via Talk Markets · April 29, 2026
Automotive Filters Market Share, Growth & Size Reporttalkmarkets.com
Via Talk Markets · April 29, 2026
The 5 Most Interesting Analyst Questions From Cathay General Bancorp’s Q1 Earnings Call
Cathay General Bancorp’s first quarter performance saw revenue and profit results above Wall Street’s expectations, with management attributing the outcome t...
Via StockStory · April 29, 2026
5 Must-Read Analyst Questions From CACI’s Q1 Earnings Call
CACI’s first quarter performance reflected steady execution in its core defense and intelligence markets, with organic revenue growth and strong program exec...
Via StockStory · April 29, 2026
5 Must-Read Analyst Questions From Raymond James’s Q1 Earnings Call
Raymond James delivered a fiscal second quarter that surpassed Wall Street’s revenue and adjusted profit expectations, with management attributing performanc...
Via StockStory · April 29, 2026
Warehousing and Storage Market Size, Share & Growth Forecast-2035talkmarkets.com
Via Talk Markets · April 29, 2026
Body Care Cosmetics Market Size, Share & Growth Reviewtalkmarkets.com
Via Talk Markets · April 29, 2026
Herbal Soap Market Size, Growth & Share Insights-2035talkmarkets.com
Via Talk Markets · April 29, 2026
Hernia Repair Devices Market Growth, Share & Size Trends 2026-2035talkmarkets.com
Via Talk Markets · April 29, 2026
BEN Q1 Deep Dive: Diversified Flows, Private Markets Momentum, and Strategic Tech Investments
Global investment management firm Franklin Resources (NYSE:BEN) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 8.7% ye...
Via StockStory · April 29, 2026
SHW Q1 Deep Dive: Targeted Pricing, Raw Material Volatility, and Aggressive Share Gains
Paint and coating manufacturer Sherwin-Williams (NYSE:SHW) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 6.8% year on y...
Via StockStory · April 29, 2026
5 Insightful Analyst Questions From Kinder Morgan’s Q1 Earnings Call
Kinder Morgan delivered a first quarter that surpassed Wall Street revenue and non-GAAP profit expectations, with management crediting robust demand for natu...
Via StockStory · April 29, 2026
INCY Q1 Deep Dive: Pipeline Advances Offset Cautious Full-Year Guidance
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 20.9% year on year to $1.27 bi...
Via StockStory · April 29, 2026
An Overview of 5-MeO-DIPT in Research Contextstalkmarkets.com
Via Talk Markets · April 29, 2026
Understanding Research Compound Properties and Contexttalkmarkets.com
Via Talk Markets · April 29, 2026
AWI Q1 Deep Dive: Margin Pressures Offset Solid Revenue Growth and Product Momentum
Ceiling and wall solutions company Armstrong World Industries (NYSE:AWI) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.1% year on year...
Via StockStory · April 29, 2026
IVZ Q1 Deep Dive: Invesco's Global Flows, Platform Expansion, and Margin Pressures
Asset management firm Invesco (NYSE:IVZ) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 14% year on year to $1.26 billion. Its non-GAAP p...
Via StockStory · April 29, 2026
CNC Q1 Deep Dive: Margin Expansion and Risk Adjustment Shape Outlook
Health coverage company Centene (NYSE:CNC) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.1% year on year to $49.94 billion. The compa...
Via StockStory · April 29, 2026
SYY Q1 Deep Dive: Local Volume Momentum and Restaurant Depot Deal Drive Strategic Shift
Food distribution giant Sysco (NYSE:SYY) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 4.7% year on year to $20.52 billion. Its non-GAAP...
Via StockStory · April 29, 2026
ECE Department & Admissions 2026-27 | RRCE Bangaloretalkmarkets.com
Via Talk Markets · April 29, 2026
Book Meghalaya Tour Package from Guwahati – Explore Waterfalls, Caves & Hillstalkmarkets.com
Via Talk Markets · April 29, 2026
ALLE Q1 Deep Dive: Margin Pressures, International Setbacks, and Electronics Drive Outlook
Security hardware provider Allegion (NYSE:ALLE) announced better-than-expected revenue in Q1 CY2026, with sales up 9.7% year on year to $1.03 billion. Its no...
Via StockStory · April 29, 2026
ZBH Q1 Deep Dive: Sales Force Changes, Tech Investments, and Margin Expansion Shape Outlook
Medical device company Zimmer Biomet (NYSE:ZBH) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 9.3% year on year to $2...
Via StockStory · April 29, 2026
KO Q1 Deep Dive: Strong Consumer Demand and Balanced Growth Drive Outperformance
Beverage company Coca-Cola (NYSE:KO) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 11.2% year on year to $12.47 billio...
Via StockStory · April 29, 2026
HLT Q1 Deep Dive: U.S. Demand Momentum and Global Expansion Offset Regional Headwinds
Hotel company Hilton (NYSE:HLT) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 9% year on year to $2.94 billion. Its non-GAAP p...
Via StockStory · April 29, 2026
TRU Q1 Deep Dive: AI-Driven Product Demand and Mortgage Momentum Offset Margin Pressures
Credit reporting company TransUnion (NYSE:TRU) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 13.7% year on year to $1.2...
Via StockStory · April 29, 2026
CECO Q1 Deep Dive: Orders Surge and Thermon Merger Set to Transform Portfolio
Environmental solutions provider CECO Environmental (NASDAQ:CECO) announced better-than-expected revenue in Q1 CY2026, with sales up 16.5% year on year to $2...
Via StockStory · April 29, 2026
Zevia (ZVIA): Buy, Sell, or Hold Post Q4 Earnings?
Shareholders of Zevia would probably like to forget the past six months even happened. The stock dropped 47.3% and now trades at $1.25. This was partly drive...
Via StockStory · April 29, 2026
3 Reasons to Avoid NNBR and 1 Stock to Buy Instead
NN’s 35% return over the past six months has outpaced the S&P 500 by 31%, and its stock price has climbed to $2.57 per share. This performance may have inves...
Via StockStory · April 29, 2026
2 Reasons to Watch S and 1 to Stay Cautious
Over the past six months, SentinelOne’s stock price fell to $14.60. Shareholders have lost 13.5% of their capital, which is disappointing considering the S&P...
Via StockStory · April 29, 2026
3 Reasons to Sell ENOV and 1 Stock to Buy Instead
Enovis’s stock price has taken a beating over the past six months, shedding 26.8% of its value and falling to $23.41 per share. This might have investors con...
Via StockStory · April 29, 2026
3 Reasons to Sell COLL and 1 Stock to Buy Instead
Over the last six months, Collegium Pharmaceutical’s shares have sunk to $32.78, producing a disappointing 5.8% loss - a stark contrast to the S&P 500’s 4% g...
Via StockStory · April 29, 2026